| http://dbpedia.org/ontology/abstract
|
Fagron, tot 31 december 2014 Arseus genaam … Fagron, tot 31 december 2014 Arseus genaamd, is een Belgisch-Nederlands beursgenoteerde onderneming op het gebied van gezondheidszorg. Het hoofdkantoor is gevestigd in Rotterdam, maar het bedrijf is geregistreerd in het Vlaamse Nazareth. Het was voorheen een divisie van het Belgische bedrijf Omega Pharma en is in 2007 afgescheiden van dit concern middels een beursgang. Het bedrijf is actief in 30 landen en heeft ongeveer 2000 werknemers. Het aandeel Fagron/Arseus was vanaf maart 2014 opgenomen in de AMX Index aan Euronext maar werd in maart 2016 verdrongen naar de AScX Index. In juni 2019 keerde het aandeel terug in de AMX-index. keerde het aandeel terug in de AMX-index.
, Fagron NV is a publicly traded multination … Fagron NV is a publicly traded multinational group of companies governed by Belgian law. Its registered office is located in Waregem, Belgium, and its headquarters is located at Rotterdam, Netherlands. Founded as Arseus NV, it was formerly the Professional Health Division of Omega Pharma, and became an independent entity via an IPO on October 5, 2007 and has been listed on NYSE Euronext Brussels and NYSE Euronext Amsterdam since then. Its share is included in the BEL MID-index and the Amsterdam Small Cap Index (AScX). The head office of Fagron is located in Rotterdam (the Netherlands).is located in Rotterdam (the Netherlands).
|
| http://dbpedia.org/ontology/industry
|
http://dbpedia.org/resource/Healthcare +
|
| http://dbpedia.org/ontology/numberOfEmployees
|
2000
|
| http://dbpedia.org/ontology/predecessor
|
http://dbpedia.org/resource/Omega_Pharma +
|
| http://dbpedia.org/ontology/regionServed
|
http://dbpedia.org/resource/Europe +
, http://dbpedia.org/resource/United_States +
, http://dbpedia.org/resource/South_America +
|
| http://dbpedia.org/ontology/type
|
http://dbpedia.org/resource/Public_company +
|
| http://dbpedia.org/ontology/wikiPageExternalLink
|
https://www.reuters.com/finance/stocks/RCUS.BR/key-developments/article/2456486 +
, https://www.reuters.com/finance/stocks/RCUS.BR/key-developments/article/2541050 +
, https://fagron.com/en +
, https://www.reuters.com/finance/stocks/RCUS.BR/key-developments/article/1964679 +
, https://www.reuters.com/finance/stocks/RCUS.BR/key-developments/article/2047761 +
, https://www.reuters.com/finance/stocks/RCUS.BR/key-developments/article/2051353 +
, http://www.standaard.be/Artikel/Detail.aspx%3FartikelId=DMF20090714_015 +
, https://archive.today/20130201053645/http:/www.reuters.com/finance/stocks/RCUS.BR/key-developments/article/2360332 +
, http://www.standaard.be/artikel/detail.aspx%3Fartikelid=DMF20100416_013 +
, https://archive.today/20130201073111/http:/www.reuters.com/finance/stocks/RCUS.BR/key-developments/article/2413637 +
, https://www.reuters.com/finance/stocks/RCUS.BR/key-developments/article/2337663 +
, https://www.reuters.com/finance/stocks/RCUS.BR/key-developments/article/2360332 +
, http://www.hln.be/hln/nl/942/Economie/article/detail/133930/2008/01/15/Omzet-Arseus-stijgt-volgens-verwachting-met-10-procent.dhtml +
, https://www.reuters.com/finance/stocks/RCUS.BR/key-developments/article/2361073 +
, https://www.reuters.com/finance/stocks/RCUS.BR/key-developments/article/2413637 +
|
| http://dbpedia.org/ontology/wikiPageID
|
35591818
|
| http://dbpedia.org/ontology/wikiPageLength
|
9682
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1112787634
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/United_States +
, http://dbpedia.org/resource/Category:Companies_based_in_Rotterdam +
, http://dbpedia.org/resource/Initial_public_offering +
, http://dbpedia.org/resource/Category:Holding_companies_established_in_2007 +
, http://dbpedia.org/resource/Omega_Pharma +
, http://dbpedia.org/resource/Multinational_corporation +
, http://dbpedia.org/resource/NYSE_Euronext +
, http://dbpedia.org/resource/Category:Health_care_companies_of_the_Netherlands +
, http://dbpedia.org/resource/Waregem +
, http://dbpedia.org/resource/Pharmaceutical_drug +
, http://dbpedia.org/resource/Healthcare +
, http://dbpedia.org/resource/Europe +
, http://dbpedia.org/resource/Belgium +
, http://dbpedia.org/resource/Registered_office +
, http://dbpedia.org/resource/Netherlands +
, http://dbpedia.org/resource/Brussels_Stock_Exchange +
, http://dbpedia.org/resource/Rotterdam +
, http://dbpedia.org/resource/Public_company +
, http://dbpedia.org/resource/South_America +
, http://dbpedia.org/resource/Software +
|
| http://dbpedia.org/property/areaServed
|
Europe, South America and the United States
|
| http://dbpedia.org/property/homepage
|
https://fagron.com/en +
|
| http://dbpedia.org/property/industry
|
Healthcare services and products
|
| http://dbpedia.org/property/locationCity
|
http://dbpedia.org/resource/Rotterdam +
|
| http://dbpedia.org/property/locationCountry
|
http://dbpedia.org/resource/Netherlands +
|
| http://dbpedia.org/property/name
|
Fagron NV
|
| http://dbpedia.org/property/numEmployees
|
over 2,000
|
| http://dbpedia.org/property/predecessor
|
http://dbpedia.org/resource/Omega_Pharma +
|
| http://dbpedia.org/property/tradedAs
|
RCUS.BR on the Brussels Stock Exchange
|
| http://dbpedia.org/property/type
|
http://dbpedia.org/resource/Public_company +
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Infobox_company +
, http://dbpedia.org/resource/Template:Citation_needed +
, http://dbpedia.org/resource/Template:Official +
, http://dbpedia.org/resource/Template:Cite_web +
, http://dbpedia.org/resource/Template:Reflist +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Holding_companies_established_in_2007 +
, http://dbpedia.org/resource/Category:Health_care_companies_of_the_Netherlands +
, http://dbpedia.org/resource/Category:Companies_based_in_Rotterdam +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Fagron?oldid=1112787634&ns=0 +
|
| http://xmlns.com/foaf/0.1/homepage
|
https://fagron.com/en +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Fagron +
|
| http://xmlns.com/foaf/0.1/name
|
Fagron NV
|
| owl:sameAs |
http://www.wikidata.org/entity/Q4796496 +
, http://nl.dbpedia.org/resource/Fagron +
, https://global.dbpedia.org/id/4Smro +
, http://dbpedia.org/resource/Fagron +
|
| rdf:type |
http://dbpedia.org/ontology/Agent +
, http://www.wikidata.org/entity/Q4830453 +
, http://www.wikidata.org/entity/Q43229 +
, http://schema.org/Organization +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#SocialPerson +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#Agent +
, http://dbpedia.org/ontology/Organisation +
, http://dbpedia.org/ontology/Company +
, http://www.wikidata.org/entity/Q24229398 +
|
| rdfs:comment |
Fagron, tot 31 december 2014 Arseus genaam … Fagron, tot 31 december 2014 Arseus genaamd, is een Belgisch-Nederlands beursgenoteerde onderneming op het gebied van gezondheidszorg. Het hoofdkantoor is gevestigd in Rotterdam, maar het bedrijf is geregistreerd in het Vlaamse Nazareth. Het was voorheen een divisie van het Belgische bedrijf Omega Pharma en is in 2007 afgescheiden van dit concern middels een beursgang. Het bedrijf is actief in 30 landen en heeft ongeveer 2000 werknemers. landen en heeft ongeveer 2000 werknemers.
, Fagron NV is a publicly traded multination … Fagron NV is a publicly traded multinational group of companies governed by Belgian law. Its registered office is located in Waregem, Belgium, and its headquarters is located at Rotterdam, Netherlands. Founded as Arseus NV, it was formerly the Professional Health Division of Omega Pharma, and became an independent entity via an IPO on October 5, 2007 and has been listed on NYSE Euronext Brussels and NYSE Euronext Amsterdam since then. Its share is included in the BEL MID-index and the Amsterdam Small Cap Index (AScX). The head office of Fagron is located in Rotterdam (the Netherlands).is located in Rotterdam (the Netherlands).
|
| rdfs:label |
Fagron
|
